Bayer Intellectual Property Gmbh

Boehringer Ingelheim International Gmbh

Bayer Schering Pharma Ag

Bayer Healthcare Aktiengesellschaft

Bayer Schering Pharma Aktiengesellshaft

Christina Erb

Marja Van Kampen

Joachim Luithle

Martin Hendrix

Frank-Gerhard Böβ

Christoph Methfessel

Frank-Thorsten Hafner

Katrin Schnizler

Franz-Josef Van Der Staay

Timo Flessner

Timo Fleβner

Adrian Tersteegen

Welf-Burkhard Wiese

Dieter Lang

Lars Bärfacker

Heike Heckroth

Dagmar Karthaus

Rudy Schreiber

Frank-Gerhard Böss

Joachim Krüger

Frank Wunder

Nils Burkhardt

Frank-Gerhard Boess

Frank-Gerhard Bob

Marja V Kampen

Ulrich Ebert

Bettina Beyreuther

Frank-Gerhard BÖβ

Frank-Gerhard Böß

Frank-Gerhard Böb

Katrin Schnitzler

Yan-Hong Liu

Welf Burkhard Wiese

Frank Gerhard Boess

Frank-Gerhard Boss

Joachim Krueger

The invention relates to novel heteroaryl carboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

Heteroaryl carboxamides

The invention relates to novel amides of acetic and propionic acids, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.

Amides of acetic and propionic acids

The invention relates to novel 2-heteroaryl carboxamides and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

2-heteroaryl carboxamides

The invention relates to novel benzothiophene-, benzofuran-, and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning, and/or memory.

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

The invention relates to novel heteroaryl carboxamides, a process for their preparation, and pharmaceutical compositions containing them. These materials are useful for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

The invention relates to the use of selective phosphodiesterase 9A (PDE9A) inhibitors for producing medicaments for improving perception, concentration, cognitive processes, learning and/or memory.

Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes

The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

2-heteroarylcarboxylic acid amides

The invention relates to 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation, and their use for producing medicaments for improving learning and/or memory. The 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines are of the formula (I): with the variables as defined in the claims.

6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines

Growing community of inventors

Kriftel, Germany

Christina Erb